ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2004

Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.

Francis J Ruiz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.